
CAPR
Capricor Therapeutics Inc
Biotechnology
Capricor Therapeutics Inc (CAPR) Insider Trading
5 transactions reported on SEC Form 4 — executive and director buys and sells.
Buys
0
Sells
2
Net value
$-1.5M
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Bergmann Anthony | CHIEF FINANCIAL OFFICER | Exercise | 24,100 | $76.6K | Jun 25, 2026 |
| Bergmann Anthony | CHIEF FINANCIAL OFFICER | Sell | 24,100 | $732.2K | Jun 25, 2026 |
| Krasney Karen | EVP, GENERAL COUNSEL | Exercise | 24,100 | $76.6K | Jun 25, 2026 |
| Krasney Karen | EVP, GENERAL COUNSEL | Sell | 24,100 | $732.2K | Jun 25, 2026 |
| Maurer Michael T | CHIEF COMMERCIAL OFFICER | Grant | 80,000 | — | May 26, 2026 |